In celebration of National Science Week 2020, Solubility is supporting the#InspiringAustraliaInitiative by profiling five dynamic scientific careers.
Next up in our daily interview series is Dr Ian Nisbet.
What does your role entail?
Cartherics is harnessing the body’s immune system to target and kill cancer […]
By Leigh Dayton
“It’s good to get new money into Cartherics,” says the Cartherics’ Chief Scientific Officer Richard Boyd. He adds that the AU$120,000 in grant funding is particularly welcome as all Melbourne-based research and development (R&D) groups are managing the hurdles of […]
By Leigh Dayton
8 July 2020
Cartherics will take part in the Onco Cell Therapy Summit 2020 virtual conference 8-10 July AEST. Cartherics CEO Alan Trounson, Chief Scientific Officer Richard Boyd and lead scientists will join an international gathering of key decision makers for CAR-T therapies.
The Summit, […]
It’s hardly news. COVID-19 is a global threat. By the end of May 2020 it had killed 356,000 people worldwide and 103 Australians. The cost to the global economy is estimated in the trillions of dollars and Governments around the […]
| ‘Dear Dr Balachandran Suraiya,
It gives me great pleasure to inform you that Professor Margaret Gardner AO – President and Vice-Chancellor, in accordance with the delegated authority of the Monash University Council, has conferred the award Doctor Of […] |
By Leigh Dayton, Cartherics Communications Advisor
The global COVID-19 pandemic affects all Australians, their friends and family, at home and abroad. It is having a profound and enduring impact on our society, our resilience and our health.
So, when the President of the Australian Academy of Science (AAS), John Shine, called upon researchers […]
In Australia, one woman loses her battle with ovarian cancer every eight hours. That is why Cartherics supports World Ovarian Cancer Day and the 130 organisations which promote it.
On May 8th members of the World Ovarian Cancer Coalition come together to raise awareness of ovarian cancer and the need […]
When the first anticancer therapies based on engineered T cells hit the market a few years ago, they offered the possibility of what would have once been perceived as a medical miracle: a one-shot cure for certain blood cancers. Chimeric antigen receptor (CAR) T cell therapies, […]
By Leigh Dayton, Cartherics Communication Advisor
It happens every Thursday. Cartherics team members gather for a Virtual Coffee Break. Everyone brings their caffeine of choice and fronts up to their home computer screen for a […]
By Leigh Dayton
Image from Left to right : Dr Richard Boyd (Supervisor), Anisha Balachandran, Dr Nick Boyd (Co-Supervisor).
She joined the Cartherics Cooperative Research Centre (CRC-P) PhD Program two years ago with a top reputation. Now, Anisha Balachandran is garnering even more kudos for the quality […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
